-
November 15, 2021 DEA Quadruples Psilocybin Manufacturing for Research in Final 2021 Production QuotasDrug Enforcement Agency also hugely boosts MDMA and DMT quotas “in response to the nationwide...
-
November 12, 2021 Psychedelic Business Spotlight: November 12This week in psychedelic business news: two of the biggest players in the industry unveil...
-
November 11, 2021 Canada Reaches Psychedelic Milestone with First Legal Group Psilocybin Therapy SessionAnd the results, according to the participants, were nothing short of "profound."
-
November 10, 2021 MAPS Expands MDMA-Assisted Therapy for PTSD Trial Into CanadaRick Doblin's organization partners with Numinus Wellness to manage the Canadian sites where therapists will...
-
November 9, 2021 Largest Psilocybin Therapy Trial Ever Conducted Shows Depressive Symptoms Rapidly Reduce“A single dose of psilocybin generated a rapid response that lasted up to 12 weeks,”...
-
November 8, 2021 Cybin Unveils Data Suggesting Its Novel Psilocybin Analog Is the ‘Superior Molecule’Pre-clinical studies demonstrated multiple advantages, including less patient variability, faster onset of action, shorter duration...
-
November 5, 2021 Psychedelic Business Spotlight: November 5This week in psychedelic business news: DEA grants Cybin a Schedule I manufacturing license; PharmaTher...
-
November 4, 2021 FDA Approves First Clinical Trial Using Naturally Sourced PsychedelicsThis trial, using Filament Health's botanical drug candidates, is the first to assess the direct...
-
November 3, 2021 Detroit Voters Decriminalize Plant PsychedelicsAs the decriminalization movement sweeps through Michigan, Detroit becomes the largest city in the state...
-
November 2, 2021 Lil Nas X Says Psychedelics Helped Him ‘Open Up’ to Write Debut Album ‘Montero’Pop star says in new interview that tripping on psilocybin enabled him, for the first...
